leadf
logo-loader
viewPsyched Wellness

Psyched Wellness says it received 'positive' results from its Maximum Tolerated Dosage study of AME-1

The study is the first set of thorough toxicology assessments on the company's Amanita Muscaria extract, AME-1

Psyched Wellness - Psyched Wellness Ltd says it received “positive'' results from its Maximum Tolerated Dosage study conducted by KGK Science
CEO Jeff Stevens: 'Today's results pushes us one step closer to our goal of applying to the FDA for a New Dietary Ingredient and to Health Canada for a Natural Health Product Number'

Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) (FRA:5U9), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, announced Tuesday that it has received the results from its Maximum Tolerated Dosage (MTD) study of AME-1 conducted by KGK Science. 

"I am pleased to share the positive results from the individual studies that our CRO is conducting in the pre-clinical study on our behalf for AME-1," Jeff Stevens, CEO of Psyched Wellness, said in a statement. "Today's results pushes us one step closer to our goal of applying to the FDA for a New Dietary Ingredient and to Health Canada for a Natural Health Product Number." 

Psyched Wellness said the study is the first set of thorough toxicology assessments on the company's Amanita Muscaria extract, AME-1. The MTD study summarizes the maximum tolerated dose and LD50 thresholds for AME-1.  

READ: Psyched Wellness closes a bought deal private placement for total gross proceeds of $6,603,000

This significant set of information obtained permits for the next step of pre-clinical studies involving a 14- and 90-day oral toxicity to further identify a safe, effective dose for human consumption, the company said.

"This is a key first step in the toxicological assessment of AME-1 that is the foundation for the next set of preclinical studies further identifying the properties of AME-1," said Brian Tancowny, scientific advisor to the company. 

"For centuries Amanita Muscaria has been embraced by cultures due to its restorative and rejuvenating qualities and with these results, Psyched Wellness is well on its way to delivering a clinically tested and medically approved product that will effectively treat, repair and nurture the mind, body and soul.”

Psyched Wellness is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods.

The company's objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. It is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas, and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Quick facts: Psyched Wellness

Price: 0.25 CAD

CSE:PSYC
Market: CSE
Market Cap: $20.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Psyched Wellness named herein, including the promotion by the Company of Psyched Wellness in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Psyched Wellness: Partly psychedelics and partly consumer wellness

Proactive Research analyst Ed Stacey takes a closer look at Psyched Wellness Ltd (CSE: PSYC) (OTCQB: PSYCF), a health supplements company developing a unique range of products which harness the properties of a specific type of mushroom. The functional mushrooms market is a large and...

20 hours, 57 minutes ago

2 min read